MEDICA 2023 + COMPAMED 2023 Show the Way Forward in Healthcare
|
By LabMedica International staff writers Posted on 13 Nov 2023 |

An audience of medical professionals from across the world and all areas of the healthcare economy is coming together once again in Düsseldorf, Germany as the internationally leading medical trade fair MEDICA (Düsseldorf, Germany) kicks off on November 13 to 16, 2023, with an unprecedented number of participants including over 5,300 companies from close to 70 countries. COMPAMED, which is held in parallel, is the international leading trade fair for suppliers within the medical technology industry, where about 730 companies from 39 countries are participating. After German companies, the largest bookings of floor space has been from China, Italy, Turkey, South Korea, the USA and other European nations such as France, Spain, the United Kingdom and Poland. At COMPAMED, the USA, Italy and Switzerland are at the top behind Germany.
In the halls of the trade fair grounds, exhibitors are presenting a comprehensive range of medical products, devices and instruments for outpatient and clinical treatment which covers all phases of development, production and marketing. MEDICA determines its focus areas in its five worlds of experience covering the huge range of over 10,000 company innovations related to lab technology and diagnostics, medical technology and electromedicine, commodities and consumables, physiotherapy and orthopedic technology as well as IT systems and IT solutions. The highlights of each MEDICA, in addition to the numerous innovations, traditionally also include multi-faceted accompanying programs with celebrity visits and presentations. Moreover, the keynote speakers are expected to particularly spice up the specialist topics.
The on-stage program of the accompanying conferences and the professional forums integrated into the worlds of experience is offering several other highlights. These include the finals of two start-up competitions on the stage of the MEDICA CONNECTED HEALTHCARE FORUM (Hall 12). At the 12th MEDICA Start-up COMPETITION on Tuesday afternoon (14 November), the focus is on the entire spectrum of innovations for the healthcare sector: from artificial intelligence (AI) to health apps, solutions for laboratory diagnostics and medical robotics. For the first time this year, “sustainability” features as a novel category. The 15th “Healthcare Innovation Worldcup” on Monday afternoon (13 November), by contrast, focuses on intelligent “Internet of Medical Things” (IoMT) solutions such as digital biomarkers, smart bandages and network-connectible wearables.
A key trend currently shaping the market is the growing trend of “outpatientisation”. This puts the focus on “point-of-care” products and services that includes patient-oriented diagnostics and treatment, as well as telemedical applications for optimal, cross-sector networking among all those involved in the care process. Other current key trends are procedures based on artificial intelligence (AI) and supporting systems, such as robotic systems or VR/AR (virtual reality/augmented reality) applications, as well as solutions for the implementation of more sustainable processes along the supply and added value chain.
At COMPAMED 2023 in the trade fair Halls 8a and 8b, medical technology industry suppliers are showing what they are capable of. The exhibiting companies are also presenting (five) worlds of experience including a wide range of high-tech and service solutions. The five worlds of experience are: Manufacturing & Devices (e.g., components, parts, manufacturing processes), Services & Advice (e.g., research, development, services), Materials (e.g., plastics, glass, ceramics, metals, composite materials, adhesives, packaging), Micro Tech (such as micro components, microfluidics) as well as IT in Tech (software development and maintenance for medical technology). The program sessions, the COMPAMED HIGH-TECH FORUM and the COMPAMED SUPPLIERS FORUM will be following important industry and technological trends and provide practical information related to new procedures, products and relevant aspects of work on international markets.
Related Links:
MEDICA
Latest Medica 2023 News
- Absology Showcases Latest Advancements in Medical Diagnostics
- Noul Showcases AI-Driven Blood and Cancer Diagnostic Platform
- Oruba Presents State-of-the-Art Self-Operating Uroflowmeters
- Awareness Technology Exhibits Incredibly Flexible ChemWell 2 ELISA and Chemiluminescent Analyzer
- BioVendor Group Demonstrates Unique IVD Platform and Immunoblot Test
- Greiner Bio-One Highlights Magnetic 3D Cell Culture Technology
- Fujirebio Showcases Range of Novel Testing Solutions
- Sentinel Diagnostics Demonstrates New SENTiNAT 200 and STAT-NAT Kits for Infectious Diseases
- DiaSys Showcases High Quality Diagnostic Reagents and System Solutions
- Randox Exhibits Full Range of Molecular Diagnostic Solutions
- Alcor Scientific Demonstrates Fully-Automated ESR Analyzers
- Bosch Healthcare Presents Vivalytic Point-of-Care PCR System
- CerTest Presents Innovations Related to VIASURE Products
- Vircell Highlights All-in-One CLIA System and Real Time PCR Kits
- Tianlong Showcases Cutting-Edge Products and Innovative Molecular Diagnostic Solutions
- Getein Biotech Exhibits Advanced POCT Analyzers
Channels
Clinical Chemistry
view channel
New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
Steroid hormone measurement is a core application of clinical mass spectrometry, which is widely regarded as a diagnostic gold standard. Access to these high-specificity methods has often been constrained... Read more
Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection
Alzheimer’s disease develops slowly, and biological changes can appear in blood many years before symptoms. While plasma assays for phosphorylated tau offer earlier detection, discerning whether these... Read moreMolecular Diagnostics
view channel
New Molecular Test Boosts Accuracy of Bile Duct Cancer Diagnosis
Bile duct strictures can arise from cancer or benign disease, but their location within ducts connecting the liver, gallbladder, and intestines complicates evaluation. Standard biopsy and cytology may... Read moreAdaptive PCR Platform Improves Consistency in Small-Batch NGS Workflows
PCR amplification during next-generation sequencing (NGS) library preparation can introduce variability, often requiring manual quantification and risking over-cycling artifacts. The issue is especially... Read more
First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies
Accurate identification of clonal immunoglobulin heavy chain (IGH) gene rearrangements is central to evaluating suspected B-cell lymphoproliferative disorders, where a single B-cell clone yields a defining... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read moreMicrobiology
view channel
Rapid Urine Test Speeds Antibiotic Selection for UTIs
Urinary tract infections are a common reason for antibiotic prescribing and have led to more than 800,000 hospital admissions across England in the past five years, according to National Health Service data.... Read more
WHO Endorses Rapid Point-of-Care Testing to Improve TB Detection
Tuberculosis (TB) remains a leading infectious killer, with more than 3,300 deaths and 29,000 new illnesses every day. Diagnostic delays and dependence on centralized laboratory networks continue to impede... Read morePathology
view channel
AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer remains a difficult decision because only a subset benefits and many undergo toxicity without gain. Genomic assays can help but are costly,... Read more
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read moreTechnology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read moreIndustry
view channel
Lunit and CellCarta Collaborate to Expand AI Pathology in CDx Development
Lunit (Seoul, South Korea), a leading provider of AI for cancer diagnostics and precision oncology, and CellCarta (Montreal, QC, Canada), a global contract research organization (CRO) laboratory serving... Read more









